Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/1995
07/26/1995EP0663911A1 Benzopyranones, method of preparing them and their use.
07/26/1995EP0663909A1 Method of obtaining 10-deacetylbaccatine iii.
07/26/1995EP0663907A1 Method of preparing taxane derivatives.
07/26/1995EP0663906A1 Method of preparing taxane derivatives.
07/26/1995EP0663903A1 1,2-dihydro-2-oxo-3-amino quinoxaline derivatives, preparation thereof and application in therapy.
07/26/1995EP0663902A1 25-carboxylic acid derivatives in the vitamin d series, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines
07/26/1995EP0663900A1 Metal-oxime chelates for use as radiopharmaceutical agents
07/26/1995EP0663899A1 Substituted kynurenines, a process for their preparation, and use as medicaments
07/26/1995EP0663839A1 Ibuprofen-h 2? antagonist combinations
07/26/1995EP0663832A1 Use of 4'-iodo-4'-deoxydoxorubicin for the treatment of amyloidosis
07/26/1995EP0663831A1 Transdermal azidothymidine
07/26/1995EP0663830A1 Method of treating lung disease with uridine triphosphates
07/26/1995EP0663829A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use
07/26/1995EP0663828A1 Compositions for treating allergic disorders using (-) cetirizine
07/26/1995EP0663827A1 Tocolytic oxytocin receptor antagonists
07/26/1995EP0663826A1 Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
07/26/1995EP0663825A1 Use of melatonin to induce sleep
07/26/1995EP0663824A1 Potassium channel activating compounds and methods of use thereof
07/26/1995EP0663823A1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
07/26/1995EP0663822A1 Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine
07/26/1995EP0663819A1 Ibuprofen-caffeine combinations
07/26/1995EP0663816A1 Novel class of phosphocholine derivatives having antifungal activity
07/26/1995EP0663812A1 Use of alkylpolyglycosides and/or o-acylated derivatives of glucose for treating hair loss.
07/26/1995EP0638101A4 Synthetic melanin.
07/26/1995EP0630181A4 Nutritional product for trauma and surgery patients.
07/26/1995EP0596929B1 Amide derivatives of antibiotic a 40926
07/26/1995EP0594570B1 Preparations containing colestyramine for reducing lipid levels
07/26/1995EP0565721B1 1,4-benzothiazepine derivative
07/26/1995EP0536197B1 Pure crystalline form of rifapentine
07/26/1995EP0527891B1 Biodegradable polyesters for sustained drug delivery
07/26/1995EP0502092B1 Oral composition for the treatment of inflammatory bowel diseases
07/26/1995EP0416037B1 Superoxide dismutase analogs having novel binding properties
07/26/1995CN1105669A Compound used as bone targetted drug with estrin structure
07/26/1995CN1105666A Novel diazabicycloalkenes and processes for the preparation thereof
07/26/1995CN1105563A Antibiotic combination
07/26/1995CN1105562A Methyl benzoate cream
07/26/1995CN1105561A Thrapeutic composition and method of using same for treatment of hangover
07/26/1995CA2140701A1 Liposome solutions
07/25/1995US5436401 Skin disorders
07/25/1995US5436400 Isolation and structure of spongistatin 1
07/25/1995US5436369 Alicyclic phospholipase A2 inhibitors
07/25/1995US5436355 Parasiticdes, bactericides
07/25/1995US5436348 Sleep disorders
07/25/1995US5436343 Thromboxane A2 receptor antagonist, thromoboxane A2 synthase inhibitor
07/25/1995US5436342 Cardiovascular disorders and muscular disorders
07/25/1995US5436341 Intermediates for 2,3-diamino-1,5-iminosugars
07/25/1995US5436337 Anticarcinogenic agents
07/25/1995US5436273 Psychoactive propargylamine derivatives used in the treatment of anxiety, psychotic states or aggression
07/25/1995US5436272 Treatment of obesity
07/25/1995US5436270 Administering arginine for bactericides and shock treatment
07/25/1995US5436269 Method for treating hepatitis
07/25/1995US5436266 Compounds
07/25/1995US5436263 Inhibit farnesylation of oncogene protein Ras
07/25/1995US5436262 Pharmacologically active derivatives of 2-(benzimidazol-2-yl)-1,3-diaminopropane
07/25/1995US5436261 Benzospiroalkene heterocyclic compounds
07/25/1995US5436258 Prevention of bone resorption
07/25/1995US5436257 Low toxicity
07/25/1995US5436255 Method of treating diseases susceptable to treatment by blocking NMDA-receptors
07/25/1995US5436253 Pyridonecarboxylic acid derivatives and mycotic infections
07/25/1995US5436252 5-aryl-3H-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
07/25/1995US5436251 Treating neuro-psychiatric disorders gastrointenstinal disorders or migranes
07/25/1995US5436247 Antiinflammatory agents or antiarthritic agents
07/25/1995US5436246 Serotonin receptor agents
07/25/1995US5436245 Phosphate substituted amino or imino acids useful as antihypertensives
07/25/1995US5436244 Antiarrhythmia agents
07/25/1995US5436243 Aminoanthraquinone derivatives to combat multidrug resistance
07/25/1995US5436242 Tetrahydrothienopyridine derivatives, furo and pyrrolo analogs thereof for inhibiting blood platelet aggregation
07/25/1995US5436241 Topical anti-inflammatory compositions containing piroxicam
07/25/1995US5436239 Administering a platelet activating factor inhibitor
07/25/1995US5436235 3-aryl-glycidic ester derivatives
07/25/1995US5436234 Eurcyl, brassidyl and nervonyl derivatives
07/25/1995US5436233 Nervous system disorders
07/25/1995US5436232 Pharmaceutical composition for peritoneal dialysis
07/25/1995US5436231 Hypertensive agents
07/25/1995US5436009 Sustained release suppositories and a process for preparation
07/25/1995US5435998 Calcium channel blocker
07/25/1995US5435997 Benzoyl peroxide, aloe vera, camphor oil, shaving irritation
07/25/1995US5435996 Moisturizing compositions containing organosilicon compounds
07/25/1995US5435990 Chelate-antibody complexes, treatment and diagnosis of cancer, tetraazacyclododecane compounds
07/25/1995EP0669824A4 Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension.
07/25/1995CA2140813A1 Use of flavolignans as adjuvants in tumor therapy
07/25/1995CA2140722A1 Beta-carboline thromboxane synthase inhibitors
07/25/1995CA2140709A1 Substituted arylureas
07/25/1995CA2139909A1 Crosslinked anion exchange particles and method for producing the particles
07/25/1995CA2022323C Excretion of potassium ion by prostanoic acid derivatives
07/25/1995CA1336436C Gamma aminobutyric acid agonists and their use in the treatment of depression and senile dementia and other forms of memory impairment
07/25/1995CA1336433C Method for preparing phosphinic acids used in preparing ace inhibitors and intermediates produced thereby
07/25/1995CA1336432C N-imidazo[1,2-b]-pyridazinyl carbamates
07/25/1995CA1336431C Thiazolo(5,4-b)azepine compounds
07/25/1995CA1336430C Therapeutic nucleosides
07/25/1995CA1336429C Piperazine derivative or its salt, process for producing the same and pharmaceutical composition comprising the same as active ingredient
07/25/1995CA1336428C Substituted dibenzocycloheptenimines
07/25/1995CA1336412C Pharmaceutical composition having synergistic effect
07/25/1995CA1336411C Veterinary composition containing cloxacillin
07/25/1995CA1336410C Products containing a calcium antagonist and a lipid-lowering agent
07/25/1995CA1336409C Tumor or cancer cell killing therapy and agents useful therefor
07/25/1995CA1336397C Methyl cellulose pharmaceutical composition
07/21/1995CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use
07/21/1995CA2140579A1 Mono- and di-esters from cinnamic acid or one of its derivatives and vitamin c; process for preparing the same and their use as antioxidants in cosmetic, pharmaceutical or food compositions
07/20/1995WO1995019434A1 Tissue-specific enhancer active in prostate